PHARMACY BUYING ASSOCIATION, INC.
Doing business as PBA HEALTH
- KANSAS CITY, MO 64120-1336
- pbahealth.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $13.1M
- Awards on record
- 82
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
PHARMACY BUYING ASSOCIATION, INC. has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About PHARMACY BUYING ASSOCIATION, INC.
- Headquarters
- KANSAS CITY, MO 64120-1336
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEICN3LREBPMXJ9
- CAGE4NFE8
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $13.1M
- Awards on record
- 82
- Top funding agencies
- Department of Veterans Affairs
25 most recent of 82 awards
36C77026P0117
Completed: Period of performance ended Oct 29, 2026EO 14398 DARUNAVIR 600MG TAB 60CT,ENTACAPONE 200MG TAB 100CT
Department of Veterans Affairs
- Obligated
- $35.9K
- Period of performance
- Aug 6, 2026 – Oct 29, 2026
36C77026P0071
Completed: Period of performance ended Jun 23, 2026SUMATRIPTAN 6MG/0.5ML INJ SYRINGE 0.5ML 2CT
Department of Veterans Affairs
- Obligated
- $514.9K
- Period of performance
- Apr 16, 2026 – Jun 23, 2026
36C77026P0094
Completed: Period of performance ended Jun 20, 2026PHARMACEUTICAL
Department of Veterans Affairs
- Obligated
- $23.4K
- Period of performance
- Jun 10, 2026 – Jun 20, 2026
36C77026P0065
Completed: Period of performance ended Jun 20, 2026ALFUZOSIN
Department of Veterans Affairs
- Obligated
- $36.4K
- Period of performance
- Apr 10, 2026 – Jun 20, 2026
36C77026P0090
Completed: Period of performance ended May 21, 2026ATENOLOL 50/CHLORTHALIDONE 25MG TAB 100CT
Department of Veterans Affairs
- Obligated
- $8K
- Period of performance
- May 21, 2026 – May 21, 2026
36C77026P0036
Completed: Period of performance ended Apr 25, 2026PHARMACEUTICALS DULOXETINE HCL 60MG/30MG/20MG
Department of Veterans Affairs
- Obligated
- $2.2M
- Period of performance
- Feb 10, 2026 – Apr 25, 2026
36C77026P0019
Completed: Period of performance ended Feb 17, 2026PEG-400 EYE DROPS
Department of Veterans Affairs
- Obligated
- $93.9K
- Period of performance
- Jan 23, 2026 – Feb 17, 2026
36C77026P0016
Completed: Period of performance ended Dec 31, 2025HYDROCORTISONE
Department of Veterans Affairs
- Obligated
- $129.1K
- Period of performance
- Oct 22, 2025 – Dec 31, 2025
36C77025P0241
Completed: Period of performance ended Sep 26, 2025FENOFIBRATE 48MG TAB 90CT
Department of Veterans Affairs
- Obligated
- $15.7K
- Period of performance
- Sep 16, 2025 – Sep 26, 2025
36C77025P0208
Completed: Period of performance ended Sep 26, 2025PHARMACEUTICALS 770-25-3-801-0371 -NATIONAL CMOP A1222 ACAMPROSATE TAB
Department of Veterans Affairs
- Obligated
- $373.5K
- Period of performance
- Aug 4, 2025 – Sep 26, 2025
36C77025P0237
Completed: Period of performance ended Sep 22, 2025CLOMIPHENE CITRATE
Department of Veterans Affairs
- Obligated
- $147.5K
- Period of performance
- Sep 11, 2025 – Sep 22, 2025
36C77025P0235
Completed: Period of performance ended Sep 19, 2025CLOMIPHENE CITRATE
Department of Veterans Affairs
- Obligated
- $239.6K
- Period of performance
- Sep 9, 2025 – Sep 19, 2025
36C77025P0211
Completed: Period of performance ended Aug 29, 2025MULTI -LINE PHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $22K
- Period of performance
- Jun 9, 2025 – Aug 29, 2025
36C77025P0180
Completed: Period of performance ended Jun 24, 2025PHARMACEUTICALS 770-25-3-801-0427 -NATIONAL CMOP IBUPROFEN
Department of Veterans Affairs
- Obligated
- $827.8K
- Period of performance
- Jun 10, 2025 – Jun 24, 2025
36C77025P0212
Completed: Period of performance ended Jun 23, 2025MYCOPHENOLATE --MOFETIL 500MG TAB, NDC: 72888-0185-05
Department of Veterans Affairs
- Obligated
- $106.6K
- Period of performance
- Jun 11, 2025 – Jun 23, 2025
36C77025P0098
Completed: Period of performance ended Jun 20, 2025PHARMACEUTICALS 762-25-1-040-0429 -TUCSON CMOP EYELID CLEANSER -(VA-25-00026198)
Department of Veterans Affairs
- Obligated
- $11.7K
- Period of performance
- Feb 7, 2025 – Jun 20, 2025
36C77025P0155
Completed: Period of performance ended Jun 16, 2025ZOLPIDEM TARTRATE, 12.5MG & 6.25MG
Department of Veterans Affairs
- Obligated
- $21.4K
- Period of performance
- May 1, 2025 – Jun 16, 2025
36C77025P0191
Completed: Period of performance ended Jun 2, 2025PHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $33.8K
- Period of performance
- May 20, 2025 – Jun 2, 2025
36C77024P0385
Completed: Period of performance ended May 13, 2025THREE LINE PHARMACEUTICAL REQUIREMENT
Department of Veterans Affairs
- Obligated
- $17.3K
- Period of performance
- Sep 9, 2024 – May 13, 2025
36C77025P0142
Completed: Period of performance ended May 5, 2025PHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $40.7K
- Period of performance
- Apr 25, 2025 – May 5, 2025
36C77024P0229
Completed: Period of performance ended Apr 30, 2025CLOMIPHENE CITRATE 50MG TAB 30 CT
Department of Veterans Affairs
- Obligated
- $646.8K
- Period of performance
- May 1, 2024 – Apr 30, 2025
36C77025P0094
Completed: Period of performance ended Apr 28, 2025PHARMACEUTICALS 765-25-1-021-0194 -HINES CMOP 4 PHARMACEUTICALS -(VA-25-00028394)
Department of Veterans Affairs
- Obligated
- $66.9K
- Period of performance
- Apr 14, 2025 – Apr 28, 2025
36C77025P0167
Completed: Period of performance ended Apr 18, 2025PHARMACEUTICALS 762-25-2-040-1251 -TUCSON CMOP FLOURIDE TOOTHPASTE -(VA-25-00054873)
Department of Veterans Affairs
- Obligated
- $55.6K
- Period of performance
- Apr 4, 2025 – Apr 18, 2025
36C77025P0153
Completed: Period of performance ended Apr 11, 2025UREA 40% CREAM 30GM
Department of Veterans Affairs
- Obligated
- $31.8K
- Period of performance
- Apr 1, 2025 – Apr 11, 2025
36C77025P0149
Completed: Period of performance ended Apr 10, 2025DIVALPROEX NA 125MG SPRINKLE CAP
Department of Veterans Affairs
- Obligated
- $8.1K
- Period of performance
- Mar 28, 2025 – Apr 10, 2025
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
36C77026P0117 EO 14398 DARUNAVIR 600MG TAB 60CT,ENTACAPONE 200MG TAB 100CT | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $35.9K | Aug 6, 2026 – Oct 29, 2026 | Completed: Period of performance ended Oct 29, 2026 |
36C77026P0071 SUMATRIPTAN 6MG/0.5ML INJ SYRINGE 0.5ML 2CT | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $514.9K | Apr 16, 2026 – Jun 23, 2026 | Completed: Period of performance ended Jun 23, 2026 |
36C77026P0094 PHARMACEUTICAL | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $23.4K | Jun 10, 2026 – Jun 20, 2026 | Completed: Period of performance ended Jun 20, 2026 |
36C77026P0065 ALFUZOSIN | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $36.4K | Apr 10, 2026 – Jun 20, 2026 | Completed: Period of performance ended Jun 20, 2026 |
36C77026P0090 ATENOLOL 50/CHLORTHALIDONE 25MG TAB 100CT | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $8K | May 21, 2026 – May 21, 2026 | Completed: Period of performance ended May 21, 2026 |
36C77026P0036 PHARMACEUTICALS DULOXETINE HCL 60MG/30MG/20MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $2.2M | Feb 10, 2026 – Apr 25, 2026 | Completed: Period of performance ended Apr 25, 2026 |
36C77026P0019 PEG-400 EYE DROPS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $93.9K | Jan 23, 2026 – Feb 17, 2026 | Completed: Period of performance ended Feb 17, 2026 |
36C77026P0016 HYDROCORTISONE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $129.1K | Oct 22, 2025 – Dec 31, 2025 | Completed: Period of performance ended Dec 31, 2025 |
36C77025P0241 FENOFIBRATE 48MG TAB 90CT | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $15.7K | Sep 16, 2025 – Sep 26, 2025 | Completed: Period of performance ended Sep 26, 2025 |
36C77025P0208 PHARMACEUTICALS 770-25-3-801-0371 -NATIONAL CMOP A1222 ACAMPROSATE TAB | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $373.5K | Aug 4, 2025 – Sep 26, 2025 | Completed: Period of performance ended Sep 26, 2025 |
36C77025P0237 CLOMIPHENE CITRATE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $147.5K | Sep 11, 2025 – Sep 22, 2025 | Completed: Period of performance ended Sep 22, 2025 |
36C77025P0235 CLOMIPHENE CITRATE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $239.6K | Sep 9, 2025 – Sep 19, 2025 | Completed: Period of performance ended Sep 19, 2025 |
36C77025P0211 MULTI -LINE PHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $22K | Jun 9, 2025 – Aug 29, 2025 | Completed: Period of performance ended Aug 29, 2025 |
36C77025P0180 PHARMACEUTICALS 770-25-3-801-0427 -NATIONAL CMOP IBUPROFEN | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $827.8K | Jun 10, 2025 – Jun 24, 2025 | Completed: Period of performance ended Jun 24, 2025 |
36C77025P0212 MYCOPHENOLATE --MOFETIL 500MG TAB, NDC: 72888-0185-05 | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $106.6K | Jun 11, 2025 – Jun 23, 2025 | Completed: Period of performance ended Jun 23, 2025 |
36C77025P0098 PHARMACEUTICALS 762-25-1-040-0429 -TUCSON CMOP EYELID CLEANSER -(VA-25-00026198) | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $11.7K | Feb 7, 2025 – Jun 20, 2025 | Completed: Period of performance ended Jun 20, 2025 |
36C77025P0155 ZOLPIDEM TARTRATE, 12.5MG & 6.25MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $21.4K | May 1, 2025 – Jun 16, 2025 | Completed: Period of performance ended Jun 16, 2025 |
36C77025P0191 PHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $33.8K | May 20, 2025 – Jun 2, 2025 | Completed: Period of performance ended Jun 2, 2025 |
36C77024P0385 THREE LINE PHARMACEUTICAL REQUIREMENT | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $17.3K | Sep 9, 2024 – May 13, 2025 | Completed: Period of performance ended May 13, 2025 |
36C77025P0142 PHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $40.7K | Apr 25, 2025 – May 5, 2025 | Completed: Period of performance ended May 5, 2025 |
36C77024P0229 CLOMIPHENE CITRATE 50MG TAB 30 CT | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $646.8K | May 1, 2024 – Apr 30, 2025 | Completed: Period of performance ended Apr 30, 2025 |
36C77025P0094 PHARMACEUTICALS 765-25-1-021-0194 -HINES CMOP 4 PHARMACEUTICALS -(VA-25-00028394) | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $66.9K | Apr 14, 2025 – Apr 28, 2025 | Completed: Period of performance ended Apr 28, 2025 |
36C77025P0167 PHARMACEUTICALS 762-25-2-040-1251 -TUCSON CMOP FLOURIDE TOOTHPASTE -(VA-25-00054873) | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $55.6K | Apr 4, 2025 – Apr 18, 2025 | Completed: Period of performance ended Apr 18, 2025 |
36C77025P0153 UREA 40% CREAM 30GM | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $31.8K | Apr 1, 2025 – Apr 11, 2025 | Completed: Period of performance ended Apr 11, 2025 |
36C77025P0149 DIVALPROEX NA 125MG SPRINKLE CAP | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $8.1K | Mar 28, 2025 – Apr 10, 2025 | Completed: Period of performance ended Apr 10, 2025 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
No SBIR/STTR awards on record
Source: SBIR.gov award records (opens in a new tab) · sync date not recorded
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
No active exclusion on record (checked Nov 14, 2026).
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · as of Nov 14, 2026
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 14, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 14, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 424210Title not in the curated listPrimarySmall business under this code’s size standard
- 325412Pharmaceutical Preparation ManufacturingSmall business under this code’s size standard
SAM.gov reports this entity as small under 2 of 2 NAICS codes. Size is determined per code (SBA size standards).
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with PHARMACY BUYING ASSOCIATION, INC.?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.